Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple Sclerosis
Three-Year Analysis Demonstrates Robust, Highly Statistically Significant Treatment Effect of Alemtuzumab ... more »
|
|||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
Sunday, December 9
by
All About MS
on Sun 09 Dec 2007 12:00 AM CST
Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple Sclerosis Three-Year Analysis Demonstrates Robust, Highly Statistically Significant Treatment Effect of Alemtuzumab ... more »
by
All About MS
on Sun 09 Dec 2007 12:00 AM CST
Hepatitis B Vaccine Not Associated with Childhood Multiple Sclerosis CHICAGO, IL – Vaccinating against the hepatitis B virus does not appear to be ... more » |
||